SCHEMBL6131743

SCHEMBL6131743

O=c1[nH]c(C2(CC3CCCCC3)C=CC=C2)nc2[nH]ncc12

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4C Q9H3R0 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RECQL P46063 1/20 0.38
TP53 P04637 1/20 0.37
PDE9A O76083 1/20 0.37
CCNT1 O60563 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
CCNH P51946 1/20 0.36
CDK5 Q00535 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876154 0.73 PDE9A (0.56) CDK2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL3002806 0.68 JAK2 (0.48) CDK2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL7883156 0.67 PDE9A (0.49) CDK2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL16649501 0.66 HTT (0.47) CDK2SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL6131742 0.61 PDE9A (0.43) CDK2ALDH1A1PDE9ACCNT1CDK1
SCHEMBL481407 0.60 DYRK1A (0.53) SMN1; SMN2ALDH1A1HTTRECQL
SCHEMBL6642975 0.60 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HTTRECQL
Oxypurinol SCHEMBL8256863 0.60 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HTTL3MBTL1RECQL
SCHEMBL4497867 0.60 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1HTTRECQL
SCHEMBL13896216 0.60 CDK2 (0.73) CDK2CCNT1CDK1CCNB1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534285-A2 SELECTIVE PHOSPHODIESTERASE 9A INHIBITORS AS MEDICAMENTS FOR IMPROVING COGNITIVE PROCESSES Bayer HealthCare AG (DE) 2005-06-01 EP disclosed
WO-2004026286-A2 SELECTIVE PHOSPHODIESTERASE 9A INHIBITORS AS MEDICAMENTS FOR IMPROVING COGNITIVE PROCESSES BAYER HEALTHCARE AG (DE) 2004-04-01 WO disclosed